71 results
Page 2 of 4
8-K
EX-99.1
sq0dig fy6a
9 May 22
Arcturus Therapeutics Announces First Quarter 2022 Financial Update and Pipeline Progress
4:20pm
8-K
EX-99.1
tbna8ak sq0h9skwar
20 Apr 22
Arcturus Announces Self-amplifying COVID-19 mRNA Vaccine Candidate ARCT-154 Meets Primary Efficacy Endpoint in Phase 3 Study
5:24pm
8-K
EX-99.1
3fqi7f23clg056 1e
28 Feb 22
Arcturus Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Update and Pipeline Progress
4:15pm
8-K
EX-99.1
qh9emlov
13 Dec 21
Arcturus Therapeutics Appoints Jing Marantz, M.D., Ph.D., M.B.A. to its Board of Directors
5:17pm
8-K
EX-14.1
cfnseqjvyhwmt3
13 Dec 21
Arcturus Therapeutics Appoints Jing Marantz, M.D., Ph.D., M.B.A. to its Board of Directors
5:17pm
8-K
EX-99.1
93y7wi c0nuxret
8 Nov 21
Arcturus Therapeutics Announces Third Quarter 2021 Financial Update and Pipeline Progress
4:18pm
8-K
EX-99.1
8tneumc t21
9 Aug 21
Arcturus Therapeutics Announces Second Quarter 2021 Financial Results and mRNA Vaccine and Therapeutics Pipeline Progress
4:02pm
8-K
EX-99.1
7tjnf7j2 hq204
10 May 21
Arcturus Therapeutics Announces First Quarter 2021 Company Overview and Financial Results and Provides New Clinical Data
4:21pm
8-K
EX-99.1
kn8rx02 22q
1 Mar 21
Arcturus Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Positive Clinical Updates
4:20pm
8-K
EX-99.1
ee7wecqukbp8nsla mss
22 Feb 21
Arcturus Therapeutics Acquires Exclusive License to mRNA Manufacturing Technology from Alexion Pharmaceuticals
5:00pm
8-K
EX-99.1
jnk83px
8 Dec 20
Arcturus Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock
9:01am
8-K
EX-99.1
yvvf4af 5qovgqw
9 Nov 20
Arcturus Therapeutics Announces Third Quarter 2020 Financial Results and Positive Clinical Updates for ARCT-810 Phase I Study and Additional ARCT-021 Interim Data
4:06pm
PRE 14A
g55vm o0qaw68
2 Oct 20
Preliminary proxy
4:20pm
8-K
EX-99.1
uu0v3 3lar4x
18 Aug 20
Arcturus Therapeutics Executes Definitive Supply Agreement with the Israeli Ministry of Health
4:01pm
8-K
EX-99.1
1wq18kynt2p6fkqu
10 Aug 20
Arcturus Therapeutics Announces Second Quarter 2020 Financial Results and Provides a Corporate Update
4:22pm